Public Relations

Ranbaxy to launch generic version of Flomax next year

Pharma company Ranbaxy Laboratories today said it will launch a generic version of the urinary disorder treatment drug-- Flomax, next year. - Fortis in talks to buy Lanka hospital chain - Ranbaxy exits generic drugs JV with Japanese firm - Japan"s largest drug maker Takeda plans India foray - Sunny re-rating of pharma companies - "We are moving towards a larger addressable market" - Avon to gain from nod to Ranbaxy"s drug "We will launch a generic version of the urinary disorder treatment Flomax in March 2010," Ranbaxy Laboratories CFO Omesh Sethi told reporters on the sidelines of a seminar here. "We would launch another big one in 2014," he said, without naming it. "We are doing well and expect a good revenue from domestic and global markets in the next financial year," Sethi said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
CM hints at action against dissident ministers
As the three dissident ministers continued their defiance against him, chief minister B S Yeddyurappa today talked tough, hinting at "stern action" against them. "These people cannot cow me down. They are worried about my popularity graph," Yeddyurappa told reporters here, as he hit back at the three ministers who had launched a strong attack on him at a function in their home district of Bellary yesterday.
Popular Articles
Modern furniture stores in nyc

Honda Siel Cars expects double digit sales growth this year
Honda Siel Cars India (HSCI), the Indian subsidiary of the Japanese giant Honda Motor Co, today said that its sales will register double digit growth in the current financial year. The company expects its total sales to be around 60,000-65,000 units during the current year, up from 55,250 cars sold in 2008-09.

'Cement prices expected to weaken in Oct-March period'
The woes of the cement industry are likely to continue as prices are likely to weaken during the remaining period of the current fiscal on the back of highest ever capacity addition by the industry in a single year.